Rajesh B Parekh's Net Worth
$1.19 Million
Who is Rajesh B Parekh?
Rajesh B Parekh has an estimated net worth of $1.19 Million. This is based on reported shares across multiple companies, which include Aura Biosciences, Inc., Celldex Therapeutics, Inc., and Eloxx Pharmaceuticals, Inc..
SEC CIK
Rajesh B Parekh's CIK is 0001429930
Past Insider Trading and Trends
2021 was Rajesh B Parekh's most active year for acquiring shares with 7 total transactions. Rajesh B Parekh's most active month to acquire stocks was the month of March. 2008 was Rajesh B Parekh's most active year for disposing of shares, totalling 3 transactions. Rajesh B Parekh's most active month to dispose stocks was the month of August. 2021 saw Rajesh B Parekh paying a total of $3,329,999.10 for 5,058,270 shares, this is the most they've acquired in one year. In 2008 Rajesh B Parekh cashed out on 56,223 shares for a total of $630,282.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aura Biosciences, Inc. (AURA) Snapshot price: $8.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celldex Therapeutics, Inc. (CLDX) Snapshot price: $38.195
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Sep 22
| |||
Form 4
|
∞
| 40K |
$3.73 | $149,348.00 | 40K |
Sep 13
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
| -100.00% | -56.22K |
$11.21 | -$630,282.23 |
0
|
Sep 8 - Sep 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eloxx Pharmaceuticals, Inc. (ELOX) Snapshot price: $0.82125
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +97.41% | 2.47M |
$1.35 | $3,329,999.10 | 5M |
May 13
| |||
Form 4
|
∞
| 2.53M |
—
|
—
| 2.53M |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||